We are at the cutting edge of a rapidly changing market and have a significant opportunity as gene editing and gene modulation become embedded at an industrial scale into our customers’ workflows. The market opportunity for gene editing and gene modulation is substantial and with limited direct competition, Horizon has strong prospects for growth. With a robust balance sheet and an already strong order book for 2019, we are confident in our growth prospects. The Board expects FY19 revenues to be in-line with current market expectation and to maintain a positive EBITDA performance.
Terry Pizzie, Chief Executive Officer of Horizon Discovery
Click here to see full CEO Review from Horizon’s 2018 Annual Report and Accounts